Texas Capital holds Aemetis stock with $2.00 target post-earnings

On Thursday, Texas Capital Securities maintained a Hold rating on Aemetis (NASDAQ:AMTX) stock, with an unchanged price target of $2.00, while the stock currently trades at $1.79. According to InvestingPro data, analyst targets for the company range from $3 to $28, though the company’s overall financial health score remains weak at 1.61 out of 5. Analyst Derrick Whitfield provided insights into the company’s recent financial release, identifying both strengths and weaknesses in their performance.

The analyst acknowledged several positive aspects, such as the ethanol plant’s results exceeding expectations, robust dairy Renewable Natural Gas (RNG) sales volumes in the fourth quarter of 2024, and capital expenditures coming in below projections. While these highlights indicate some operational successes for Aemetis, InvestingPro data shows the company faces significant challenges with a current ratio of 0.26 and negative EBITDA of $27.98 million in the last twelve months.

However, Whitfield also pointed out significant concerns, particularly the lower-than-anticipated quarterly EBITDA and a substantial drop in biodiesel sales. The latter issue was attributed to a delay in Open Market Committee (OMC) tender offers, which impacted the company’s performance in the Indian market.

Despite these mixed results, the focus for investors, according to Whitfield, will likely shift to the company’s prospects and strategic plans for 2025. This forward-looking sentiment is expected to be a key point of interest during today’s earnings call.

The balance of positive and negative factors led to the decision by Texas Capital Securities to maintain the current stock rating and price target for Aemetis. The firm’s stance reflects caution amidst Aemetis’ varied quarterly outcomes, with investor attention turning to future company guidance.

In other recent news, Aemetis, Inc. reported $112 million in revenues from its Indian subsidiary, Universal Biofuels, following the restart of biodiesel production. The company is also planning an initial public offering (IPO) for this subsidiary, with the potential to expand production capacity to over 200 million gallons per year. Additionally, Aemetis amended its sales agreement with H.C. Wainwright & Co., LLC, allowing for the sale of up to $210 million in common stock, enhancing its financial flexibility. The company has successfully sold $13.5 million in tax credits, netting $11 million, which supports its renewable energy projects. Aemetis’s facilities have received IRS approval for Excise Tax Registration, enabling it to claim Section 45Z Production Tax Credits under the Inflation Reduction Act. The company anticipates a significant increase in renewable natural gas (RNG) production, supported by USDA guaranteed loans and additional financing. Furthermore, Aemetis announced pay raises and bonuses for its top executives, reflecting its commitment to aligning executive interests with strategic objectives. These developments highlight Aemetis’s ongoing efforts to advance its operations and financial strategies in the renewable fuels sector.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.